1. Wang N#*, Li D#, Zhang T#, Pachai MR, Schoeps DM, Bao Y, Cho WH, Khudoynazarova MN, Kristoff K, Liu M, Tang L, Janjigian YY, Chi P*, Chen Y*. Loss of Kmt2c/d promotes gastric cancer and confers vulnerability to mTORC1 and PD1 inhibition. J Clin Invest. 2026 May 12;. doi: 10.1172/JCI194462. PubMed PMID: 42118591.
2. Li D#*, Wang N#, Guo W#, Owiredu J#, Cho WH, Schoeps D, Cheng S, Zhang H, Chan UI, Wong CK, Callychurn VR, Wang H, Kang W, Fan N, Pasolli HA, Sharma A, Gopalan A, Barbieri CE, Gao D*, Chi P*, Chen Y*. Cell-Autonomous AR Dependence in Luminal Prostatic Epithelium Governs Survival and Lineage Plasticity. bioRxiv. 2026 Feb 16;. doi: 10.64898/2026.02.13.705807. PubMed PMID: 41757036.
3. Wang N#, Pachai MR#, Li D#, Lee CJ, Warda S, Khudoynazarova MN, Cho WH, Xie G, Shah SR, Yao L, Qian C, Wong EWP, Yan J, Tomas FV, Hu W, Kuo F, Gao SP, Luo J, Smith AE, Han M, Gao D, Ge K, Yu H, Chandarlapaty S, Iyer GV, Rosenberg JE, Solit DB, Al-Ahmadie HA, Chi P*, Chen Y*. Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters. Nat Genet. 2025 Jan;57(1):165-179. doi: 10.1038/s41588-024-02015-y. PubMed PMID: 39806204.
4. Li D#, Zhan Y#, Wang N#, Tang F, Lee CJ, Bayshtok G, Moore AR, Wong EWP, Pachai MR, Xie Y, Sher J, Zhao JL, Khudoynazarova M, Gopalan A, Chan J, Khurana E, Shepherd P, Navone NM, Chi P*, Chen Y*. ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer. Sci Adv. 2023 Apr 5;9(14):eadc9446. doi: 10.1126/sciadv.adc9446. PubMed PMID: 37018402.
5. Wang N#, Hakimi AA, Chen Y*. XL-ing at Induction of Apoptosis in Kidney Cancer through Inhibition of BCL-XL. Clin Cancer Res. 2022 Nov 1;28(21):4600-4602. doi: 10.1158/1078-0432.CCR-22-2104. PubMed PMID: 35984355.
6. Wang N#, Dong BJ#, Quan Y, Chen Q, Chu M, Xu J, Xue W, Huang YR, Yang R*, Gao WQ*. Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status. Stem Cell Reports. 2016 May 10;6(5):668-678. doi: 10.1016/j.stemcr.2016.04.007. PubMed PMID: 27167157.
7. Wang N#, Yao M, Xu J, Quan Y, Zhang K, Yang R*, Gao WQ*. Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK-Mediated Phosphorylation of Akt. Clin Cancer Res. 2015 Oct 15;21(20):4676-85. doi: 10.1158/1078-0432.CCR-14-3163. PubMed PMID: 26071486.
用户登录
还没有账号?
立即注册